{
     "PMID": "15953419",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20050816",
     "LR": "20161122",
     "IS": "0896-6273 (Print) 0896-6273 (Linking)",
     "VI": "46",
     "IP": "6",
     "DP": "2005 Jun 16",
     "TI": "Rap2-JNK removes synaptic AMPA receptors during depotentiation.",
     "PG": "905-16",
     "AB": "The related small GTPases Ras and Rap1 are important for signaling synaptic AMPA receptor (-R) trafficking during long-term potentiation (LTP) and long-term depression (LTD), respectively. Rap2, which shares 60% identity to Rap1, is present at excitatory synapses, but its functional role is unknown. Here, we report that Rap2 activity, stimulated by NR2A-containing NMDA-R activation, depresses AMPA-R-mediated synaptic transmission via activation of JNK rather than Erk1/2 or p38 MAPK. Moreover, Rap2 controls synaptic removal of AMPA-Rs with long cytoplasmic termini during depotentiation. Thus, Rap2-JNK pathway, which opposes the action of the NR2A-containing NMDA-R-stimulated Ras-ERK1/2 signaling and complements the NR2B-containing NMDA-R-stimulated Rap1-p38 MAPK signaling, channels the specific signaling for depotentiating central synapses.",
     "FAU": [
          "Zhu, Yinghua",
          "Pak, Daniel",
          "Qin, Yi",
          "McCormack, Stefanie G",
          "Kim, Myung J",
          "Baumgart, Joel P",
          "Velamoor, Vanisree",
          "Auberson, Yves P",
          "Osten, Pavel",
          "van Aelst, Linda",
          "Sheng, Morgan",
          "Zhu, J Julius"
     ],
     "AU": [
          "Zhu Y",
          "Pak D",
          "Qin Y",
          "McCormack SG",
          "Kim MJ",
          "Baumgart JP",
          "Velamoor V",
          "Auberson YP",
          "Osten P",
          "van Aelst L",
          "Sheng M",
          "Zhu JJ"
     ],
     "AD": "Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.",
     "LA": [
          "eng"
     ],
     "GR": [
          "R01 NS051241/NS/NINDS NIH HHS/United States",
          "R01 NS051241-01A1/NS/NINDS NIH HHS/United States"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, N.I.H., Extramural",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "United States",
     "TA": "Neuron",
     "JT": "Neuron",
     "JID": "8809320",
     "RN": [
          "0 (Enzyme Inhibitors)",
          "0 (Excitatory Amino Acid Agonists)",
          "0 (Excitatory Amino Acid Antagonists)",
          "0 (Receptors, AMPA)",
          "0 (Recombinant Proteins)",
          "0 (glutamate receptor ionotropic, AMPA 1)",
          "0 (glutamate receptor ionotropic, AMPA 2)",
          "147336-22-9 (Green Fluorescent Proteins)",
          "6384-92-5 (N-Methylaspartate)",
          "76326-31-3 (2-amino-5-phosphopentanoic acid)",
          "77521-29-0 (alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid)",
          "EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases)",
          "EC 3.6.5.2 (rap GTP-Binding Proteins)",
          "HG18B9YRS7 (Valine)",
          "I38ZP9992A (Magnesium)"
     ],
     "SB": "IM",
     "EIN": [
          "Neuron. 2005 Jul 21;47(2):321"
     ],
     "MH": [
          "Animals",
          "Animals, Newborn",
          "Blotting, Western/methods",
          "Cells, Cultured",
          "Drug Interactions",
          "Electric Stimulation/methods",
          "Enzyme Inhibitors/pharmacology",
          "Excitatory Amino Acid Agonists/pharmacology",
          "Excitatory Amino Acid Antagonists/pharmacology",
          "Fluorescent Antibody Technique/methods",
          "Gene Expression Regulation/drug effects/physiology",
          "Green Fluorescent Proteins/metabolism",
          "Hippocampus/cytology",
          "In Vitro Techniques",
          "JNK Mitogen-Activated Protein Kinases/classification/*metabolism",
          "Long-Term Synaptic Depression/*physiology",
          "Magnesium/pharmacology",
          "Models, Neurological",
          "Mutagenesis/physiology",
          "N-Methylaspartate/pharmacology",
          "Neurons/drug effects/physiology",
          "Patch-Clamp Techniques/methods",
          "Phosphorylation/drug effects",
          "Rats",
          "Receptors, AMPA/*metabolism",
          "Recombinant Proteins/biosynthesis",
          "Synaptic Transmission/*physiology",
          "Time Factors",
          "Transfection/methods",
          "Valine/*analogs & derivatives/pharmacology",
          "alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology",
          "rap GTP-Binding Proteins/*metabolism"
     ],
     "EDAT": "2005/06/15 09:00",
     "MHDA": "2005/08/17 09:00",
     "CRDT": [
          "2005/06/15 09:00"
     ],
     "PHST": [
          "2004/11/03 00:00 [received]",
          "2005/03/29 00:00 [revised]",
          "2005/04/25 00:00 [accepted]",
          "2005/06/15 09:00 [pubmed]",
          "2005/08/17 09:00 [medline]",
          "2005/06/15 09:00 [entrez]"
     ],
     "AID": [
          "S0896-6273(05)00407-1 [pii]",
          "10.1016/j.neuron.2005.04.037 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuron. 2005 Jun 16;46(6):905-16. doi: 10.1016/j.neuron.2005.04.037.",
     "term": "hippocampus"
}